“…r-Hirudin, whose efficacy in venous and arterial thrombosis has been widely studied (Ten-Cate, 1996), could be an attractive therapeutic agent in LPS-induced DIC, as is suggested by previous work in several experimental models (Ishikawa et al, 1980;Hoffmann et al, 1990;Zawilska et al, 1993;Hermida et al, 1998). On the other hand, fibrinolytic activators have been found to be useful in different animal models of thrombosis and DIC (Matsuo et al, 1981;Korninger et al, 1982;Collen et al, 1983;Agnelli et al, 1985;Schneider, 1993;Paloma et al, 1995;Hardaway et al, 1996).…”